Xiaoqiang Ding

机构：Zhongshan Hospital · ORCID：0000-0001-7620-1886

发表论文 17 篇 · 总被引 225 次 · h-index 5

代表论文

• METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1 (2021 · Cell Death and Disease · 被引 118)
• Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP 3 inflammasome activation (2016 · Journal of Cellular and Molecular Medicine · 被引 53)
• Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury (2016 · Oncotarget · 被引 23)
• Rapamycin reduces renal hypoxia, interstitial inflammation and fibrosis in a rat model of unilateral ureteral obstruction (2014 · Clinical and investigative medicine · 被引 17)
• FTO aggravates podocyte injury and diabetic nephropathy progression via m6A-dependent stabilization of ACC1 mRNA and promoting fatty acid metabolism (2025 · Biochemical Pharmacology · 被引 13)
• 14-3-3ζ Targets β-Catenin Nuclear Translocation to Maintain Mitochondrial Homeostasis, Promoting Balance of Proliferation and Apoptosis in Cisplatin-Induced AKI (2023 · Journal of the American Society of Nephrology)